Literature DB >> 9397490

Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus. A five-year follow-up study.

B Hultberg1, C D Agardh, E Agardh, M Lövestam-Adrian.   

Abstract

In a previous study, we showed that diabetic patients exhibited significantly increased concentrations of total plasma homocysteine (tHcy), but not until the onset of nephropathy. It was suggested that the hyperhomocysteinaemia might contribute to the accelerated atherosclerotic process in diabetic patients. In the present study, we have analysed the main determinants of plasma homocysteine (i.e. serum cobalamin, blood folate and serum creatinine), and also some other parameters related to diabetes mellitus, such as medical history, metabolic and renal quantities, on two occasions with a 5-year interval in 50 patients with insulin-dependent diabetes mellitus, in order to further elucidate the relation between plasma tHcy and diabetes mellitus. The result of the present study shows that diabetic patients with the lowest age at onset and with the poorest metabolic control are those most prone to a rapid increase in plasma tHcy concentration. The increment in plasma tHcy concentration in this group of patients may at least partly be explained by a marginal deficiency of blood folate concentrations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9397490     DOI: 10.3109/00365519709055282

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  8 in total

1.  Plasma homocysteine levels in noninsulin-dependent diabetes mellitus with retinopathy and neovascular glaucoma.

Authors:  Iclal Yücel; Gültekin Yücel; Filiz Müftüoglu
Journal:  Int Ophthalmol       Date:  2005-09-29       Impact factor: 2.031

2.  Total homocysteine, diet, and lipid profiles in type 1 and type 2 diabetic and nondiabetic adolescents.

Authors:  Melissa Spezia Faulkner; Wei-Hsun Chao; Savitri K Kamath; Laurie Quinn; Cynthia Fritschi; Jack A Maggiore; Robert H Williams; Robert D Reynolds
Journal:  J Cardiovasc Nurs       Date:  2006 Jan-Feb       Impact factor: 2.083

Review 3.  Drugs affecting homocysteine metabolism: impact on cardiovascular risk.

Authors:  Cyrus Desouza; Mary Keebler; Dennis B McNamara; Vivian Fonseca
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes.

Authors:  H C Looker; A Fagot-Campagna; E W Gunter; C M Pfeiffer; K M Venkat Narayan; W C Knowler; R L Hanson
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

5.  The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy.

Authors:  Barbara E K Klein; Michael D Knudtson; Michael Y Tsai; Ronald Klein
Journal:  Arch Ophthalmol       Date:  2009-09

6.  Evaluation of serum vitamin B12 levels in type 1 diabetics attending a tertiary care hospital: A preliminary cross - sectional study.

Authors:  Ann Sarah Koshy; S Jaya Kumari; Vageesh Ayyar; Prasanna Kumar
Journal:  Indian J Endocrinol Metab       Date:  2012-03

7.  Age and kidney function are the primary correlates of fasting plasma total homocysteine levels in non-diabetic and diabetic adults. Results from the 1999-2002 National Health and Nutrition Examination Survey.

Authors:  Glen E Duncan; Sierra M Li; Xiao-Hua Zhou
Journal:  Nutr Metab (Lond)       Date:  2005-05-26       Impact factor: 4.169

Review 8.  Involvements of Hyperhomocysteinemia in Neurological Disorders.

Authors:  Marika Cordaro; Rosalba Siracusa; Roberta Fusco; Salvatore Cuzzocrea; Rosanna Di Paola; Daniela Impellizzeri
Journal:  Metabolites       Date:  2021-01-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.